Alpha-Adrenergic Mechanisms in the Cardiovascular Hyperreactivity to Norepinephrine-Infusion in Essential Hypertension

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Aug 8

PMID 35937820

Authors

Lisa-Marie Walther

Roland von Kanel

Nadja Heimgartner

Claudia Zuccarella-Hackl

Guido Stirnimann

Petra H Wirtz

Affiliations

Soon will be listed here.

Abstract

Aims: Essential hypertension (EHT) is characterized by cardiovascular hyperreactivity to stress but underlying mechanism are not fully understood. Here, we investigated the role of α-adrenergic receptors (α-AR) in the cardiovascular reactivity to a norepinephrine (NE)-stress reactivity-mimicking NE-infusion in essential hypertensive individuals (HT) as compared to normotensive individuals (NT).

Methods: 24 male HT and 24 male NT participated in three experimental trials on three separate days with a 1-min infusion followed by a 15-min infusion. Trials varied in infusion-substances: placebo saline (Sal)-infusions (trial-1:Sal+Sal), NE-infusion without (trial-2:Sal+NE) or with non-selective α-AR blockade by phentolamine (PHE) (trial-3:PHE+NE). NE-infusion dosage (5g/ml/min) and duration were chosen to mimic duration and physiological effects of NE-release in reaction to established stress induction protocols. We repeatedly measured systolic (SBP) and diastolic blood pressure (DBP) as well as heart rate before, during, and after infusions.

Results: SBP and DBP reactivity to the three infusion-trials differed between HT and NT ('s≤.014). HT exhibited greater BP reactivity to NE-infusion alone compared to NT (trial-2-vs-trial-1: 's≤.033). Group differences in DBP reactivity to NE disappeared with prior PHE blockade (trial-3: =.26), while SBP reactivity differences remained (trial-3: =.016). Heart rate reactivity to infusion-trials did not differ between HT and NT (=.73).

Conclusion: Our findings suggest a mediating role of α-AR in DBP hyperreactivity to NE-infusion in EHT. However, in SBP hyperreactivity to NE-infusion in EHT, the functioning of α-AR seems impaired suggesting that the SBP hyperreactivity in hypertension is not mediated by α-AR.

Citing Articles

Acute mental stress-induced alpha or beta-adrenergic reactivity patterns linked to unique cardiometabolic risk profiles.

Wentzel A, Naude D, von Kanel R Sci Rep. 2025; 15(1):8668.

PMID: 40082568 PMC: 11906893. DOI: 10.1038/s41598-025-92961-2.

Physiological reactivity to acute mental stress in essential hypertension-a systematic review.

Walther L, Wirtz P Front Cardiovasc Med. 2023; 10:1215710.

PMID: 37636310 PMC: 10450926. DOI: 10.3389/fcvm.2023.1215710.

Pro-arrhythmic role of adrenergic spatial densities in the human atria: An in-silico study.

Magtibay K, Masse S, Nanthakumar K, Umapathy K PLoS One. 2023; 18(8):e0290676.

PMID: 37624832 PMC: 10456151. DOI: 10.1371/journal.pone.0290676.

Hyperreactivity of Salivary Alpha-Amylase to Acute Psychosocial Stress and Norepinephrine Infusion in Essential Hypertension.

Walther L, von Kanel R, Zuccarella-Hackl C, Wirtz P Biomedicines. 2022; 10(7).

PMID: 35885066 PMC: 9312828. DOI: 10.3390/biomedicines10071762.

References

Chapman N, Chen C, Fujita T, Hobbs F, Kim S, Staessen J . Time to re-appraise the role of alpha-1 adrenoceptor antagonists in the management of hypertension?. J Hypertens. 2010; 28(9):1796-803. DOI: 10.1097/HJH.0b013e32833b912c. View

Ram C, Anderson R, HART G, Crumpler C . Alpha adrenergic blockade by prazosin in therapy of essential hypertension. Clin Pharmacol Ther. 1981; 29(6):719-22. DOI: 10.1038/clpt.1981.101. View

Kjeldsen S, Os I, Westheim A, Lande K, Gjesdal K, Hjermann I . Hyper-responsiveness to low-dose epinephrine infusion in mild essential hypertension. J Hypertens Suppl. 1988; 6(4):S581-3. DOI: 10.1097/00004872-198812040-00182. View

Jie K, van Brummelen P, Vermey P, Timmermans P, van Zwieten P . Postsynaptic alpha 1- and alpha 2-adrenoceptors in human blood vessels: interactions with exogenous and endogenous catecholamines. Eur J Clin Invest. 1987; 17(2):174-81. DOI: 10.1111/j.1365-2362.1987.tb02397.x. View

McEwen B . Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci. 1998; 840:33-44. DOI: 10.1111/j.1749-6632.1998.tb09546.x. View

Ferrier C, Weidmann P . Alpha 1-adrenergic blockade and cardiovascular pressor responses in essential hypertension. Hypertension. 1986; 8(5):407-14. DOI: 10.1161/01.hyp.8.5.407. View

Manger W, Frohlich E, Gifford R, DUSTAN H . Norepinephrine infusion in normal subjects and patients with essential or renal hypertension: effect on blood pressure, heart rate, and plasma catecholamine concentrations. J Clin Pharmacol. 1976; 16(2-3):129-41. DOI: 10.1002/j.1552-4604.1976.tb02394.x. View

Topouchian J, El Assaad M, Orobinskaia L, El Feghali R, Asmar R . Validation of two automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension: the Omron M6 (HEM-7001-E) and the Omron R7 (HEM 637-IT). Blood Press Monit. 2006; 11(3):165-71. DOI: 10.1097/01.mbp.0000209078.17246.34. View

Andresen M, Yang M . Arterial baroreceptor resetting: contributions of chronic and acute processes. Clin Exp Pharmacol Physiol Suppl. 1989; 15:19-30. DOI: 10.1111/j.1440-1681.1989.tb02993.x. View

10.

Altunkan S, Ilman N, Kayaturk N, Altunkan E . Validation of the Omron M6 (HEM-7001-E) upper-arm blood pressure measuring device according to the International Protocol in adults and obese adults. Blood Press Monit. 2007; 12(4):219-25. DOI: 10.1097/MBP.0b013e3280f813d0. View

11.

Bombelli M, Facchetti R, Fodri D, Brambilla G, Sega R, Grassi G . Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: data from the PAMELA study. Nutr Metab Cardiovasc Dis. 2012; 23(7):650-6. DOI: 10.1016/j.numecd.2012.01.004. View

12.

Augusto J, Teboul J, Radermacher P, Asfar P . Interpretation of blood pressure signal: physiological bases, clinical relevance, and objectives during shock states. Intensive Care Med. 2010; 37(3):411-9. DOI: 10.1007/s00134-010-2092-1. View

13.

Nyklicek I, Bosch J, Nieuw Amerongen A . A generalized physiological hyperreactivity to acute stressors in hypertensives. Biol Psychol. 2005; 70(1):44-51. DOI: 10.1016/j.biopsycho.2004.11.013. View

14.

Pessina A, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A . Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Nutr Metab Cardiovasc Dis. 2006; 16(2):137-47. DOI: 10.1016/j.numecd.2005.04.005. View

15.

Lee D, Lu Z, DeQuattro V . Neural mechanisms in primary hypertension. Efficacy of alpha-blockade with doxazosin during stress. Am J Hypertens. 1996; 9(1):47-53. DOI: 10.1016/0895-7061(95)00261-8. View

16.

Schmitt J, Joyner M, Charkoudian N, Wallin B, Hart E . Sex differences in alpha-adrenergic support of blood pressure. Clin Auton Res. 2010; 20(4):271-5. PMC: 3012387. DOI: 10.1007/s10286-010-0061-y. View

17.

Silverberg A, Shah S, Haymond M, Cryer P . Norepinephrine: hormone and neurotransmitter in man. Am J Physiol. 1978; 234(3):E252-6. DOI: 10.1152/ajpendo.1978.234.3.E252. View

18.

Balint E, Jarczok M, Langgartner D, Reber S, Endes S, Schmidt-Trucksass A . Heightened Stress Reactivity in Response to an Attachment Related Stressor in Patients With Medically Treated Primary Hypertension. Front Psychiatry. 2021; 12:718919. PMC: 8459015. DOI: 10.3389/fpsyt.2021.718919. View

19.

Chida Y, Steptoe A . Greater cardiovascular responses to laboratory mental stress are associated with poor subsequent cardiovascular risk status: a meta-analysis of prospective evidence. Hypertension. 2010; 55(4):1026-32. DOI: 10.1161/HYPERTENSIONAHA.109.146621. View

20.

Richards D, Woodings E, Prichard B . Circulatory and alpha-adrenoceptor blocking effects of phentolamine. Br J Clin Pharmacol. 1978; 5(6):507-13. PMC: 1429377. DOI: 10.1111/j.1365-2125.1978.tb01665.x. View